---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-016006"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T06:03:45.223938+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Lixte terminates unused $10M at-the-market sales agreement with WestPark Capital

## Summary
- Terminated ATM agreement dated Sept 20, 2021; no sales were ever made under it.
- Agreement allowed sale of up to $10M of common stock through WestPark Capital.
- Termination effective May 9, 2023; no financial impact or penalty noted.

## SEC filing metadata
- accession: 0001493152-23-016006
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315223016006/0001493152-23-016006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315223016006/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-016006
- JSON: https://secwatch.observer/filing/0001493152-23-016006.json
- Plain text: https://secwatch.observer/filing/0001493152-23-016006.txt

## Key facts
- Material Agreements
  LIXTE BIOTECHNOLOGY HOLDINGS, INC. terminated Sales Agreement with WestPark Capital, Inc. valued at up to $10,000,000 (effective 2023-05-09).
  - Action: termination
  - Agreement: atm program
  - Counterparty: WestPark Capital, Inc.
  - Value: up to $10,000,000
  - Effective: 2023-05-09
  source text: Item 1.02 Termination of a Material Definitive Agreement. At-the-Market Sales Agreement Effective May 9, 2023, Lixte Biotechnology Holdings, Inc. (the “Company”) terminated the at-the-market sales agreement (the “Sales Agreement”), dated September 20, 2021, with WestPark Capital, Inc. (“WestPark Capital”) relating to the possible sale of up to $10,000,000 of shares of its common stock, from time to time, through WestPark Capital.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1335105/000149315223016006/0001493152-23-016006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.